Form 8-K PLUS THERAPEUTICS, INC. For: Mar 08

Go back to Form 8-K PLUS THERAPEUTICS, INC. For: Mar 08

Plus Therapeutics (PSTV) Receives Nasdaq Non-compliance Notice

March 14, 2024 5:04 PM EDT

On March 8, 2024, Plus Therapeutics (NASDAQ: PSTV) received a letter (the Notice) from the Listing Qualifications staff of The Nasdaq Stock Market (Nasdaq) notifying the Company that it no longer complies with the requirement under Nasdaq Listing Rule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders equity for continued listing on the Nasdaq Capital Market (the Equity Standard) or the alternative requirements of having a market value of listed securities of $35 million or net income from continuing... More